Difference between revisions of "Part:BBa K548000"

m
Line 6: Line 6:
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here
 
===Usage and Biology===
 
===Usage and Biology===
 +
 +
Aequorin was discovered in Aequorea aequorea, a species of bioluminescent jellyfish first purified in 1962 by Osamu Shimomura. This protein emitted light at the correct wavelength, and required calcium as a cofactor, which allowed us to easily adapt it for use in our light activated ion channel cell signaling system. In the presence of its substrate, coelenterazine, Aequorin could release blue light that would have, in theory been able to activate the light-gated ion channels our cells would use to receive messages.
 +
 +
We characterized our new biobrick with a series of experiments intended to show two things:
 +
 +
1.Our newly synthesized gene could produce a measurable quantity of blue light
 +
2.Our newly synthesized gene could only produce light in the presence of Ca2+
 +
 +
As our luminometer experiments show, both Ca2+ and coelenterazine are required for substantial production of light. In fact, when compared to Aequorin alone, a mixture of Ca2+ and coelenterazine produced more than 10000 times more light. Furthermore, note that a lack of Ca2+ reduced light output by 1000 times, when compared to the light output of Aequorin in the presence of Ca2+ and coelenterazine. Through this experiment, we have shown that not only can our biobrick produce blue light, but that this production of light is heavily Ca2+ dependent.
  
 
<!-- -->
 
<!-- -->

Revision as of 21:26, 28 September 2011

Humanized Aequorin

This BioBrick is a human cell line optimized version of Aequorin, a bioluminescent protein found in various jellyfish and other marine organisms. The protein requires Ca2+ for catalytic activity and oxidizes its substrate, coelenterazine to emit blue light (λmax=469nm). Aequorin is NOT a fluorescent protein, it does not require an excitation light source to emit light. Transfection of the gene into 293T cells using lipofectamine has been confirmed. The part contains EcoRI and PstI restrictions sites, and is ligated to the iGEM pSB1C3 backbone. This backbone provides chloramphenicol resistance.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 62
    Illegal NgoMIV site found at 226
  • 1000
    COMPATIBLE WITH RFC[1000]